459 filings
Page 2 of 23
425
i57k 1o0usc7h
18 Sep 24
Business combination disclosure
8:40am
8-K
9a4aw4ymq2
18 Sep 24
Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences
8:35am
425
0m84w49
11 Sep 24
Business combination disclosure
8:40am
8-K
zephm
11 Sep 24
Kintara Therapeutics Provides Update on Corporate Developments and REM-001 Clinical Study
8:35am
425
ugarock25fylex5fk
9 Sep 24
Business combination disclosure
4:10pm
8-K
6utze7j32f s7f
9 Sep 24
Regulation FD Disclosure
4:05pm
425
75s6cs7df
3 Sep 24
Business combination disclosure
5:25pm
8-K
9iwd2m0bsl1hta
3 Sep 24
Your vote “FOR” each proposal will allow for the completion of the proposed merger with TuHURA
5:20pm
425
xilqogdzk3630j qnhkn
19 Aug 24
Business combination disclosure
9:10am
8-K
mj41hoxx8j6bhg
19 Aug 24
Regulation FD Disclosure
9:05am
424B3
1bto5kkb
16 Aug 24
Prospectus supplement
6:43pm
EFFECT
1lcn e63jykp
14 Aug 24
Notice of effectiveness
12:15am
8-K
hetnbm4z4pyi
12 Jul 24
Amendments to Articles of Incorporation or Bylaws
5:17pm
425
xujxw o26
8 Jul 24
Business combination disclosure
6:45am
8-K
fnajk6g6
8 Jul 24
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.’s KVA12123 Novel anti-VISTA Checkpoint Inhibitor
6:40am
425
35nzwto9vmbohx
1 Jul 24
Business combination disclosure
8:40am
8-K
2rz8z kpas
1 Jul 24
Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones
8:35am